Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Primary laryngeal lymphoma

S M Ansell1, T M Habermann, J D Hoyer

  • 1Division of Hematology and Internal Medicine, Mayo Clinic, Rochester, Minnesota 55905, U.S.A.

The Laryngoscope
|November 22, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Evaluation of the efficacy of GnRH-a pretreatment before total hysterectomy for adenomyosis patients: a propensity score matching analysis].

Zhonghua fu chan ke za zhi·2023
Same author

Report of consensus panel 7 from the 11th international workshop on Waldenström macroglobulinemia on priorities for novel clinical trials.

Seminars in hematology·2023
Same author

Lenalidomide plus R-CHOP21 in newly diagnosed diffuse large B-cell lymphoma (DLBCL): long-term follow-up results from a combined analysis from two phase 2 trials.

Blood cancer journal·2018
Same author

[The effect of microRNA-21 on myocardial fibrosis in mice with chronic viral myocarditis].

Zhonghua xin xue guan bing za zhi·2018
Same author

Infusion of autograft natural killer cell/CD14<sup>+</sup>HLA-DR<sup>DIM</sup> cell ratio predicts survival in lymphoma post autologous stem cell transplantation.

Bone marrow transplantation·2017
Same author

A phase 1 trial of <sup>90</sup>Y-Zevalin radioimmunotherapy with autologous stem cell transplant for multiple myeloma.

Bone marrow transplantation·2017
Same journal

Practice Patterns for the Management of Pediatric oSDB: What Is the Current National Landscape?

The Laryngoscope·2026
Same journal

Vocal Fold Opening Position Impacts Bowing Measures in Age-Related Vocal Atrophy.

The Laryngoscope·2026
Same journal

Association Between the Modified Frailty Index and Short-Term Total Thyroidectomy Complications.

The Laryngoscope·2026
Same journal

Discrimination of Pairs of Chemosensory Stimuli in Relation to Respiration.

The Laryngoscope·2026
Same journal

What Safety Precautions Are Recommended When Lasering in the Airway?

The Laryngoscope·2026
Same journal

Success of Anterior Ethmoidal Artery Flaps for Nasal Septal Perforation Repair: A Systematic Review.

The Laryngoscope·2026
See all related articles

Primary laryngeal lymphoma, a rare non-Hodgkin's lymphoma, presents with varied histology. Treatment should align with specific lymphoma subtypes rather than just laryngeal location.

Area of Science:

  • Oncology
  • Hematology
  • Pathology

Background:

  • Primary laryngeal lymphoma is exceptionally rare, with limited reported cases.
  • Previous reports often involved extralaryngeal sites, further reducing the count of truly primary laryngeal cases.

Purpose of the Study:

  • To analyze a series of patients with stage IAE non-Hodgkin's lymphoma of the larynx.
  • To evaluate treatment outcomes and determine if primary laryngeal lymphoma is a distinct entity or a presentation of systemic lymphoma.

Main Methods:

  • Retrospective review of six patients diagnosed with stage IAE non-Hodgkin's lymphoma of the larynx between 1952 and 1995.
  • Histological classification using the Revised European-American Lymphoid (REAL) classification.
  • Analysis of initial therapy (radiation alone), response, relapse, and survival.

Related Experiment Videos

Main Results:

  • Initial complete remission was achieved in all six patients with radiation therapy.
  • Four patients relapsed with the same histology.
  • Five patients died from lymphoma, with a median survival of 67 months.

Conclusions:

  • The heterogeneity of histologies and variable outcomes suggest primary laryngeal lymphoma is an unusual presentation of non-Hodgkin's lymphoma.
  • Treatment decisions should be guided by the specific lymphoma histology, not solely by the limited stage and laryngeal location.
  • Further research is needed due to the rarity and heterogeneity of this condition.